Keylika

Walnut Creek, CA

Keylika developed a platform synthesis technology for mixed ligand metal complexes that is used to generate a multitude of organometallic drugs for treating a wide range of therapeutic conditions: hematology, pain and inflammation, metabolic disorders to infectious diseases and oncology.

Company Details

Founded: 2022
Employees: Between 2 - 10 employees
Raised: Unknown
Headquarters Location: Walnut Creek, CA
Public: No
Acquired: No
CEO: Buddhadev P. Chaudhuri
Founders: Frederik Ceyssens
Buddhadev P. Chaudhuri

Company Collections

These are collections Keylika is a part of. Click on the collection name to view similar companies.

Keylika's Investors

Keylika's Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

Keylika's Tech Stack